Merck (NYSE: MRK) reported sales of $16 billion for the third quarter of 2023, up 7% from the same period a year ago.
![](https://cdn.news.alphastreet.com/wp-content/uploads/2023/10/Merck-Q3-2023-Earnings-Infographic-608x1024.jpg)
GAAP net income increased 46% to $4.7 billion, or $1.86 per share, compared to last year. Adjusted EPS rose 15% to $2.13.
For the full year of 2023, the company expects worldwide sales to be $59.7-60.2 billion and adjusted EPS to be $1.33-1.38.
Prior performance
![](https://cdn.news.alphastreet.com/wp-content/uploads/2023/08/Merck-Q2-2023-Earnings-Infographic-608x1024.jpg)
![](https://cdn.news.alphastreet.com/wp-content/uploads/2023/08/Merck-Q2-2023-Earnings-Infographic-608x1024.jpg)